Literature DB >> 22871793

Depletion and reconstitution of macrophages in mice.

Shelley B Weisser1, Nico van Rooijen, Laura M Sly.   

Abstract

Macrophages are critical players in the innate immune response to infectious challenge or injury, initiating the innate immune response and directing the acquired immune response. Macrophage dysfunction can lead to an inability to mount an appropriate immune response and as such, has been implicated in many disease processes, including inflammatory bowel diseases. Macrophages display polarized phenotypes that are broadly divided into two categories. Classically activated macrophages, activated by stimulation with IFNγ or LPS, play an essential role in response to bacterial challenge whereas alternatively activated macrophages, activated by IL-4 or IL-13, participate in debris scavenging and tissue remodeling and have been implicated in the resolution phase of inflammation. During an inflammatory response in vivo, macrophages are found amid a complex mixture of infiltrating immune cells and may participate by exacerbating or resolving inflammation. To define the role of macrophages in situ in a whole animal model, it is necessary to examine the effect of depleting macrophages from the complex environment. To ask questions about the role of macrophage phenotype in situ, phenotypically defined polarized macrophages can be derived ex vivo, from bone marrow aspirates and added back to mice, with or without prior depletion of macrophages. In the protocol presented here clodronate-containing liposomes, versus PBS injected controls, were used to deplete colonic macrophages during dextran sodium sulfate (DSS)-induced colitis in mice. In addition, polarized macrophages were derived ex vivo and transferred to mice by intravenous injection. A caveat to this approach is that clodronate-containing liposomes deplete all professional phagocytes, including both dendritic cells and macrophages so to ensure the effect observed by depletion is macrophage-specific, reconstitution of phenotype by adoptive transfer of macrophages is necessary. Systemic macrophage depletion in mice can also be achieved by backcrossing mice onto a CD11b-DTR background, which is an excellent complementary approach. The advantage of clodronate-containing liposome-mediated depletion is that it does not require the time and expense involved in backcrossing mice and it can be used in mice regardless of the background of the mice (C57BL/6, BALB/c, or mixed background).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22871793      PMCID: PMC3476755          DOI: 10.3791/4105

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

1.  The putative role of inflammation in the irritable bowel syndrome.

Authors:  S M Collins; T Piche; P Rampal
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

Review 2.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

3.  Colon cancer-derived factors activate NF-κB in myeloid cells via TLR2 to link inflammation and tumorigenesis.

Authors:  Shin Maeda; Yohko Hikiba; Kei Sakamoto; Hayato Nakagawa; Yoshihiro Hirata; Yoku Hayakawa; Masao Akanuma
Journal:  Mol Med Rep       Date:  2011-08-04       Impact factor: 2.952

4.  SHIP-deficient, alternatively activated macrophages protect mice during DSS-induced colitis.

Authors:  Shelley B Weisser; Hayley K Brugger; Nicole S Voglmaier; Keith W McLarren; Nico van Rooijen; Laura M Sly
Journal:  J Leukoc Biol       Date:  2011-06-17       Impact factor: 4.962

Review 5.  Clodronate liposomes: perspectives in research and therapeutics.

Authors:  Nico van Rooijen; Esther van Kesteren-Hendrikx
Journal:  J Liposome Res       Date:  2002 Feb-May       Impact factor: 3.648

6.  Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation.

Authors:  Jean Francois Cailhier; Marina Partolina; Srilatha Vuthoori; Shengji Wu; Kyung Ko; Simon Watson; John Savill; Jeremy Hughes; Richard A Lang
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

Review 7.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications.

Authors:  N Van Rooijen; A Sanders
Journal:  J Immunol Methods       Date:  1994-09-14       Impact factor: 2.303

8.  Liposomes for specific depletion of macrophages from organs and tissues.

Authors:  Nico van Rooijen; Esther Hendrikx
Journal:  Methods Mol Biol       Date:  2010

9.  In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice.

Authors:  Meaghan M Hunter; Arthur Wang; Kuljit S Parhar; Michael J G Johnston; Nico Van Rooijen; Paul L Beck; Derek M McKay
Journal:  Gastroenterology       Date:  2010-01-04       Impact factor: 22.682

10.  Alternative activation of macrophages by IL-4 requires SHIP degradation.

Authors:  Shelley B Weisser; Keith W McLarren; Nicole Voglmaier; Christina J van Netten-Thomas; Andrey Antov; Richard A Flavell; Laura M Sly
Journal:  Eur J Immunol       Date:  2011-05-13       Impact factor: 5.532

View more
  60 in total

1.  The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome-Induced Inflammation.

Authors:  Anke Di; Shiqin Xiong; Zhiming Ye; R K Subbarao Malireddi; Satoshi Kometani; Ming Zhong; Manish Mittal; Zhigang Hong; Thirumala-Devi Kanneganti; Jalees Rehman; Asrar B Malik
Journal:  Immunity       Date:  2018-06-26       Impact factor: 31.745

2.  Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling.

Authors:  Wei Ying; Joshua Wollam; Jachelle M Ofrecio; Gautam Bandyopadhyay; Dalila El Ouarrat; Yun Sok Lee; Da Young Oh; Pingping Li; Olivia Osborn; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2017-02-13       Impact factor: 14.808

3.  Fcγ receptor III and Fcγ receptor IV on macrophages drive autoimmune valvular carditis in mice.

Authors:  Patricia M Hobday; Jennifer L Auger; Gregory R Schuneman; Stefanie Haasken; J Sjef Verbeek; Bryce A Binstadt
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

Review 4.  Sinusoidal immunity: macrophages at the lymphohematopoietic interface.

Authors:  Siamon Gordon; Annette Plüddemann; Subhankar Mukhopadhyay
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-12-11       Impact factor: 10.005

5.  Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices.

Authors:  Santiswarup Singha; Kun Shao; Yang Yang; Xavier Clemente-Casares; Patricia Solé; Antonio Clemente; Jesús Blanco; Qin Dai; Fayi Song; Shang Wan Liu; Jun Yamanouchi; Channakeshava Sokke Umeshappa; Roopa Hebbandi Nanjundappa; Pascal Detampel; Matthias Amrein; César Fandos; Robert Tanguay; Susan Newbigging; Pau Serra; Anmar Khadra; Warren C W Chan; Pere Santamaria
Journal:  Nat Nanotechnol       Date:  2017-04-24       Impact factor: 39.213

6.  Anemia induces gut inflammation and injury in an animal model of preterm infants.

Authors:  Connie M Arthur; Demet Nalbant; Henry A Feldman; Bejan J Saeedi; Jason Matthews; Brian S Robinson; Nourine A Kamili; Ashley Bennett; Gretchen A Cress; Martha Sola-Visner; Rheinallt M Jones; M Bridget Zimmerman; Andrew S Neish; Ravi M Patel; Peggy Nopoulos; Michael K Georgieff; John D Roback; John A Widness; Cassandra D Josephson; Sean R Stowell
Journal:  Transfusion       Date:  2019-03-21       Impact factor: 3.157

7.  Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy.

Authors:  Tadahiko Yanagita; Yoji Murata; Daisuke Tanaka; Sei-Ichiro Motegi; Eri Arai; Edwin Widyanto Daniwijaya; Daisuke Hazama; Ken Washio; Yasuyuki Saito; Takenori Kotani; Hiroshi Ohnishi; Per-Arne Oldenborg; Noel Verjan Garcia; Masayuki Miyasaka; Osamu Ishikawa; Yae Kanai; Takahide Komori; Takashi Matozaki
Journal:  JCI Insight       Date:  2017-01-12

8.  Intestinal proinflammatory macrophages induce a phenotypic switch in interstitial cells of Cajal.

Authors:  Xuyong Chen; Xinyao Meng; Hongyi Zhang; Chenzhao Feng; Bin Wang; Ning Li; Khalid Mohamoud Abdullahi; Xiaojuan Wu; Jixin Yang; Zhi Li; Chunlei Jiao; Jia Wei; Xiaofeng Xiong; Kang Fu; Lei Yu; Gail E Besner; Jiexiong Feng
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

9.  Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine-mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB/c Rag2-/- mouse model of inflammatory bowel disease.

Authors:  Sureshkumar Muthupalani; Zhongming Ge; Yan Feng; Barry Rickman; Melissa Mobley; Amanda McCabe; Nico Van Rooijen; James G Fox
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

10.  A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control.

Authors:  Ziyang Xu; Neethu Chokkalingam; Edgar Tello-Ruiz; Megan C Wise; Mamadou A Bah; Susanne Walker; Nicholas J Tursi; Paul D Fisher; Katherine Schultheis; Kate E Broderick; Laurent Humeau; Daniel W Kulp; David B Weiner
Journal:  Cancer Immunol Res       Date:  2020-09-10       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.